State Of Alaska, Department Of Revenue Alnylam Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.42 Billion
- Q3 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 2,030 shares of ALNY stock, worth $471,508. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,030
Previous 4,275
52.51%
Holding current value
$471,508
Previous $1.04 Million
46.24%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
641Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$3.83 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$2.93 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.22 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.22 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.15 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $28.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...